{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:10:34Z","timestamp":1792440634202,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["201803010012"],"award-info":[{"award-number":["201803010012"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.thromres.2022.09.017","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T11:54:39Z","timestamp":1664193279000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Vaccine-associated thrombocytopenia"],"prefix":"10.1016","volume":"220","author":[{"given":"GuangTing","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2022.09.017_bb0005","first-page":"1011","article-title":"Induction of autoimmune diseases following vaccinations: a review","volume":"1","author":"Hammoudi","year":"2015","journal-title":"SM Vaccine Vaccin."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1871528114666160105113046","article-title":"Vaccination and induction of autoimmune diseases","volume":"14","author":"Toussirot","year":"2015","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"11","key":"10.1016\/j.thromres.2022.09.017_bb0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/17474086.2021.1995347","article-title":"Immune thrombocytopenia","volume":"14","author":"Bussel","year":"2021","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0025","first-page":"617","article-title":"Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association, [Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)]","volume":"41","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.thromres.2022.09.017_bb0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/bloodadvances.2019001380","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866","volume":"4","author":"Neunert","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2022.09.017_bb0035","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France","volume":"124","author":"Guillaume","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.09.017_bb0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2017.05.010","article-title":"Epidemiology and management of primary immune thrombocytopenia: a nationwide population-based study in Korea","volume":"155","author":"Yun","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2022.09.017_bb0045","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert Michele","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.017_bb0050","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4161\/hv.23601","article-title":"Vaccine administration and the development of immune thrombocytopenic purpura in children","volume":"9","author":"Cecinati","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.thromres.2022.09.017_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/pch\/14.1.31","article-title":"Do childhood vaccines cause thrombocytopenia?","volume":"14","author":"Sauv\u00e9","year":"2009","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.thromres.2022.09.017_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/adc.84.3.227","article-title":"Idiopathic thrombocytopenic purpura and MMR vaccine","volume":"84","author":"Miller","year":"2001","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.017_bb0065","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Corri","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0070","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.vaccine.2006.10.054","article-title":"Vaccination associated thrombocytopenic purpura in children","volume":"25","author":"Rajantie","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0075","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents","volume":"129","author":"O'Leary Sean","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2022.09.017_bb0080","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1726-4901(10)70138-6","article-title":"Thrombocytopenic purpura following vaccination in early childhood: experience of a medical center in the past 2 decades","volume":"73","author":"Yuh-Lin","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.017_bb0085","article-title":"Acute immune thrombocytopenic purpura following oral polio vaccination","volume":"26","author":"Sinan","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2022.09.017_bb0090","article-title":"Severe immune thrombocytopenic purpura following influenza vaccination:a case report","volume":"14","author":"Ryuichi","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.thromres.2022.09.017_bb0095","first-page":"E136","article-title":"Acute Immune Thrombocytopenia following administration of Shingrix recombinant zoster vaccine","volume":"96","author":"Nicholas","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0100","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s12032-009-9305-x","article-title":"Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B","volume":"27","author":"Alessandro","year":"2010","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.017_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/INF.0b013e3181d2bb45","article-title":"Canadian Immunization Monitoring Program, and Active (IMPACT). Postvaccination thrombocytopenia in Canada","volume":"29","author":"Sauv\u00e9","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1542\/peds.2011-1111","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents","volume":"129","author":"O'Leary","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1542\/peds.2011-1111","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents","volume":"129","author":"O'Leary","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2022.09.017_bb0120","article-title":"Secondary immune thrombocytopenic purpura triggered by COVID-19","volume":"13","author":"Abi","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.017_bb0125","article-title":"Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination","volume":"14","author":"Omar","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.017_bb0130","article-title":"Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration","volume":"13","author":"Idogun Precious","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.thromres.2022.09.017_bb0135","article-title":"Severe immune thrombocytopenia after COVID-19 vaccination: report of four cases and review of the literature","volume":"92","author":"Angelo","year":"2021","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.thromres.2022.09.017_bb0140","article-title":"A case of immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination","volume":"22","author":"King Eleanor","year":"2021","journal-title":"Am.J.Case Rep."},{"key":"10.1016\/j.thromres.2022.09.017_bb0145","article-title":"A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"36","author":"Gyungah","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.thromres.2022.09.017_bb0150","first-page":"996","article-title":"Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)","volume":"138","author":"Finn-Ole","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.017_bb0155","article-title":"Secondary immune thrombocytopenia (ITP) associated with ChAdOx1 COVID-19 vaccination - a case report","volume":"5","author":"Martin","year":"2021","journal-title":"TH Open"},{"key":"10.1016\/j.thromres.2022.09.017_bb0160","article-title":"Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-a case report","volume":"5","author":"Bader","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.017_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MBC.0000000000001082","article-title":"ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand","volume":"33","author":"Noppacharn","year":"2022","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"9","key":"10.1016\/j.thromres.2022.09.017_bb0170","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1177\/09612033211021161","article-title":"Immune thrombocytopenia and COVID-19: case report and review of literature","volume":"30","author":"Rub\u00e9n","year":"2021","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.thromres.2022.09.017_bb0175","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s42399-020-00521-8","article-title":"Immune thrombocytopenia secondary to COVID 19: a systematic review","volume":"2","author":"Bhattacharjee","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"10.1016\/j.thromres.2022.09.017_bb0180","article-title":"Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data","volume":"151","author":"Raphael","year":"2021","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.thromres.2022.09.017_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40164-021-00235-0","article-title":"COVID-19 vaccination associated severe immune thrombocytopenia","volume":"10","author":"Ali","year":"2021","journal-title":"Exp.Hematol. Oncol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0190","first-page":"378","article-title":"Immune Thrombocytopenic Purpura (ITP) triggered by COVID-19 infection and vaccination","volume":"23","author":"Paula","year":"2021","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.thromres.2022.09.017_bb0195","series-title":"USA Today","article-title":"Death of Florida doctor after receiving COVID-19 vaccine under investigation","author":"Weintraub","year":"2021"},{"key":"10.1016\/j.thromres.2022.09.017_bb0200","author":"NEJM Journal Watch"},{"issue":"9396","key":"10.1016\/j.thromres.2022.09.017_bb0205","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.017_bb0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08830181003746304","article-title":"Could autoimmunity be induced by vaccination?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.017_bb0215","first-page":"217","article-title":"A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics","volume":"12","author":"Bogdanos","year":"2005","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0220","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1016\/j.vaccine.2011.04.036","article-title":"Detection of platelet-binding anti-measles and anti-rubella virus IgG antibodies in infants with vaccine-induced thrombocytopenic purpura","volume":"29","author":"Naho","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0225","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s11845-021-02614-2","article-title":"Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine","volume":"191","author":"Vrushali","year":"2022","journal-title":"Ir.J. Med. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.017_bb0230","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"Kanduc","year":"2020","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.017_bb0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/ijr.09.72","article-title":"Infection in systemic lupus erythematosus: friend or foe?","volume":"5","author":"Francis","year":"2010","journal-title":"Int. J. Clin. Rheumtol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.017_bb0240","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm0798-781","article-title":"Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry","volume":"4","author":"Horwitz","year":"1998","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0245","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3390\/ijms16022591","article-title":"Rescue effects: irradiated cells helped by unirradiated bystander cells","volume":"16","author":"Lam","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.017_bb0250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.cell.2017.07.026","article-title":"Clonal evolution of autoreactive germinal centers","volume":"170","author":"Degn","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.thromres.2022.09.017_bb0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1389202916666141223220551","article-title":"Genetics and vaccines in the era of personalized medicine","volume":"16","author":"Castiblanco","year":"2015","journal-title":"Curr. Genomics"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5414\/CNP74150","article-title":"HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine","volume":"74","author":"Santoro","year":"2010","journal-title":"Clin. Nephrol."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.017_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1189\/jlb.0709517","article-title":"Infections and autoimmunity: the multifaceted relationship","volume":"87","author":"Sfriso","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0609.2008.01207.x","article-title":"Characteristics of immune thrombocytopenic purpura: a guide for clinical practice","volume":"71","author":"Provan","year":"2009","journal-title":"Eur. J. Haematol. Suppl."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.017_bb0275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0031-1291373","article-title":"Piecing together the humoral and cellular mechanisms of immune thrombocytopenia","volume":"37","author":"Toltl","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.017_bb0280","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1538-7836.2008.03161.x","article-title":"Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura","volume":"7","author":"Kuwana","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.017_bb0285","article-title":"Immune thrombocytopenia: recent advances in pathogenesis and treatments","volume":"5","author":"Sylvain","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.thromres.2022.09.017_bb0290","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of secondary immune thrombocytopenia","volume":"46","author":"Cines Douglas","year":"2009","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0295","first-page":"1597","article-title":"Current and emerging treatments based on novel mechanisms for immune thrombocytopenia","volume":"63","author":"Qiaozhu","year":"2020","journal-title":"Sci. ChinaLife Sci."},{"key":"10.1016\/j.thromres.2022.09.017_bb0300","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Anne","year":"2017","journal-title":"J.Clin. Med."},{"key":"10.1016\/j.thromres.2022.09.017_bb0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00002018-200831050-00003","article-title":"Improving global monitoring of vaccine safety: a survey of national centres participating in the WHO Programme for International Drug Monitoring","volume":"31","author":"Megan","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.thromres.2022.09.017_bb0310","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.10.015","article-title":"Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management","volume":"156","author":"Elpis","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.thromres.2022.09.017_bb0315","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1542\/peds.2007-1578","article-title":"Vaccine Safety Datalink Team. Risk of immune thrombocytopenic purpura after measlesmumps-rubella immunization in children","volume":"121","author":"France","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2022.09.017_bb0320","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.09.017_bb0325","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1542\/peds.97.5.738","article-title":"Recurrent thrombocytopenic purpura after repeated measlesmumps-rubella vaccination","volume":"97","author":"Vlacha","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2022.09.017_bb0330","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archpedi.1994.02170030096023","article-title":"Exacerbation of chronic idiopathic thrombocytopenic purpura following measles-mumps-rubella immunization","volume":"148","author":"Drachtman","year":"1994","journal-title":"Arch Pediatr. Adolesc. Med."},{"key":"10.1016\/j.thromres.2022.09.017_bb0335","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.chom.2020.08.002","article-title":"Approaches and challenges in SARS-CoV-2 vaccine development","volume":"28","author":"Gabriel","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.thromres.2022.09.017_bb0340","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2021.04.054","article-title":"Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"39","author":"Welsh Kerry","year":"2021","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.thromres.2022.09.017_bb0345","article-title":"Immune thrombocytopenia in previously healthy individuals following SARS-CoV-2 vaccination (COVID-19 Immunization): a descriptive research of 70 instances with a focus on biomarkers, predictive outcomes, and consequences","volume":"14","author":"Sharma","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.thromres.2022.09.017_bb0350","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.2021013411","article-title":"SARS-CoV-2 vaccination and immune thrombocytopenia in de novo and pre-existing ITP patients","volume":"139","author":"Eun-Ju","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2022.09.017_bb0355","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/bloodadvances.2021006379","article-title":"COVID-19 vaccination in patients with immune thrombocytopenia","volume":"6","author":"Visser","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2022.09.017_bb0360","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-021-01408-4","article-title":"First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland","volume":"27","author":"Simpson","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.017_bb0365","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41467-022-32264-6","article-title":"Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland","volume":"13","author":"Simpson","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.017_bb0370","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.17645","article-title":"Exacerbation of immune thrombocytopenia following COVID-19 vaccination","volume":"195","author":"Kuter David","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0375","first-page":"677","article-title":"Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella","volume":"51","author":"Autret","year":"1996","journal-title":"Therapie"},{"key":"10.1016\/j.thromres.2022.09.017_bb0380","first-page":"e92","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic Thrombocytopenia","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2022.09.017_bb0385","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1136\/postgradmedj-2021-140947","article-title":"Acute immune thrombocytopenic purpura post first dose of COVID-19 vaccination","volume":"98","author":"Yi","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.thromres.2022.09.017_bb0390","article-title":"Immune thrombocytopenia purpura flare post COVID-19 vaccine","volume":"75","author":"Elrazi","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.thromres.2022.09.017_bb0395","doi-asserted-by":"crossref","first-page":"31","DOI":"10.22551\/2021.31.0802.10182","article-title":"Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine","volume":"8","author":"Cooper Katherine","year":"2021","journal-title":"Arch.Clin. Cases"},{"key":"10.1016\/j.thromres.2022.09.017_bb0400","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12185-021-03235-2","article-title":"Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual","volume":"115","author":"Asuka","year":"2022","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2022.09.017_bb0405","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1016\/j.vaccine.2021.10.030","article-title":"Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia","volume":"39","author":"Gordon Sally","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.thromres.2022.09.017_bb0410","article-title":"Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH","volume":"41","author":"Johannes","year":"2021","journal-title":"Hamostaseologie"},{"issue":"18","key":"10.1016\/j.thromres.2022.09.017_bb0415","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Sue","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"7873","key":"10.1016\/j.thromres.2022.09.017_bb0420","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia","volume":"596","author":"Angela","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2022.09.017_bb0425","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41591-021-01419-1","article-title":"COVID-19 vaccination and immune thrombocytopenia","volume":"27","author":"Pishko Allyson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2022.09.017_bb0440","article-title":"COVID-19: AstraZeneca vaccine linked with small risk of ITP, real world data show","volume":"373","author":"Jacqui","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.thromres.2022.09.017_bb0445","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s42399-021-01019-7","article-title":"Frequently relapsing post-COVID-19 immune thrombocytopenia","volume":"3","author":"Claudia","year":"2021","journal-title":"SN Compr. Clin. Med."},{"issue":"12","key":"10.1016\/j.thromres.2022.09.017_bb1000","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jamacardio.2021.3444","article-title":"Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: a review","volume":"6","author":"Rizk","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"23","key":"10.1016\/j.thromres.2022.09.017_bb2000","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8500","key":"10.1016\/j.thromres.2022.09.017_bb3000","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(86)92511-0","article-title":"Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients","volume":"2","author":"Woodruff","year":"1986","journal-title":"Lancet."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:10Z","timestamp":1758736150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822003978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":89,"alternative-id":["S0049384822003978"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.09.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-associated thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}